Abstract
A double-layer microfluidic chip integrated with a hollow fiber (HF) was developed to reconstitute the intestine-liver functionality for studying the absorption and metabolism of combination drugs. Caco-2 cells were inoculated in the HF cavity at the top of the serpentine channel to simulate the intestinal tissue for drug absorption and transport studied, and HepG2 cells, seeded in the bottom chamber, were used to mimic the liver for metabolism-related studies. Genistein and dacarbazine were selected for combination drug therapy and its effects on cell viability, hepatotoxicity, and cell cycle arrest under drug-conditioned culture were investigated. The results suggested that the combined concentration below −100 μg/mL had no significant inhibitory effect on HepG2 cell viability, and therefore HepG2 cells maintained their drug metabolism ability. When the drug concentration was increased above 250 μg/mL, HepG2 cells underwent apoptosis. Detection of metabolites by mass spectrometry proved the effective metabolism in the microchip model. This dynamic, co-culture microchip successfully provided a podium for long-term observation of absorption, transport, and metabolism of combination drugs, and could be an effective in vitro simulation model for further clinical research.
Similar content being viewed by others
References
Esch EW, Bahinski A, Huh D. Nat Rev Drug Discov, 2015, 14: 248–260
Kaitin KI. Clin Pharmacol Ther, 2010, 87: 356–361
Scannell JW, Blanckley A, Boldon H, Warrington B. Nat Rev Drug Discov, 2012, 11: 191–200
Hughes B. Nat Rev Drug Discov, 2009, 8: 93–96
Gao Q, Zhang Y, Wo S, Zuo Z. J Pharm Biomed Anal, 2014, 91: 60–67
Shin BS, Yoo SD, Kim TH, Bulitta JB, Landersdorfer CB, Shin JC, Choi JH, Weon KY, Joo SH, Shin S. Drug Metab Dispos, 2014, 42: 974–982
Henderson CJ, McLaughlin LA, Osuna-Cabello M, Taylor M, Gilbert I, McLaren AW, Wolf CR. Biochem J, 2015, 465: 478–488
Caplin JD, Granados NG, James MR, Montazami R, Hashemi N. Adv Healthc Mater, 2015, 4: 1426–1450
Lee JB, Sung JH. Biotech J, 2013, 8: 1258–1266
Bhatia SN, Ingber DE. Nat Biotechnol, 2014, 32: 760–772
Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A. Drug Discov Today, 2011, 17: 173–181
Neuži P, Giselbrecht S, Länge K, Huang TJ, Manz A. Nat Rev Drug Discov, 2012, 11: 620–632
Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Science, 2010, 328: 1662–1668
Mu X, Zheng W, Xiao L, Zhang W, Jiang X. Lab Chip, 2013, 13: 1612–1618
Kim HJ, Huh D, Hamilton G, Ingber DE. Lab Chip, 2012, 12: 2165–2174
Choe A, Ha SK, Choi I, Choi N, Sung JH. Biomed Microdevices, 2017, 19: 4
Wagner I, Materne EM, Brincker S, Sü ssbier U, Frädrich C, Busek M, Sonntag F, Sakharov DA, Trushkin EV, Tonevitsky AG, Lauster R, Marx U. Lab Chip, 2013, 13: 3538–3547
Jie M, Li HF, Lin L, Zhang J, Lin JM. RSC Adv, 2016, 6: 54564–54572
Imura Y, Yoshimura E, Sato K. Anal Chem, 2013, 85: 1683–1688
Imura Y, Sato K, Yoshimura E. Anal Chem, 2010, 82: 9983–9988
Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hü bner J, Lindner M, Drewell C, Bauer S, Thomas A, Sambo NS, Sonntag F, Lauster R, Marx U. Lab Chip, 2015, 15: 2688–2699
Markowitz M, Evering TH, Garmon D, Caskey M, La Mar M, Rodriguez K, Sahi V, Palmer S, Prada N, Mohri H. J Acquir Immune Defic Syndr, 2014, 66: 140–147
Liu Y, Fei T, Zheng X, Brown M, Zhang P, Liu XS, Wang H. Sci Rep, 2016, 6: 22120
Chou TC. Cancer Res, 2010, 70: 440–446
Kim J, Taylor D, Agrawal N, Wang H, Kim H, Han A, Rege K, Jayaraman A. Lab Chip, 2012, 12: 1813–1822
Du GS, Pan JZ, Zhao SP, Zhu Y, den Toonder JMJ, Fang Q. Anal Chem, 2013, 85: 6740–6747
Chen Q, Wu J, Zhang Y, Lin JM. Anal Chem, 2012, 84: 1695–1701
Mao S, Zhang J, Li H, Lin JM. Anal Chem, 2013, 85: 868–876
Zhang J, Wu J, Li H, Chen Q, Lin JM. Biosens Bioelectron, 2015, 68: 322–328
Prot JM, Maciel L, Bricks T, Merlier F, Cotton J, Paullier P, Bois FY, Leclerc E. Biotechnol Bioeng, 2014, 111: 2027–2040
Maschmeyer I, Hasenberg T, Jaenicke A, Lindner M, Lorenz AK, Zech J, Garbe LA, Sonntag F, Hayden P, Ayehunie S, Lauster R, Marx U, Materne EM. Eur J Pharm Biopharm, 2015, 95: 77–87
van Midwoud PM, Merema MT, Verpoorte E, Groothuis GMM. Lab Chip, 2010, 10: 2778–2786
Tsamandouras N, Chen WLK, Edington CD, Stokes CL, Griffith LG, Cirit M. AAPS J, 2017, 19: 1499–1512
Pavese JM, Krishna SN, Bergan RC. Am J Clin Nutr, 2014, 100: 431S–436S
Yang Z, Zhu W, Gao S, Xu H, Wu B, Kulkarni K, Singh R, Tang L, Hu M. J Pharm Biomed Anal, 2011, 53: 81–89
Hosoda K, Furuta T, Yokokawa A, Ogura K, Hiratsuka A, Ishii K. Drug Metab Dispos, 2008, 36: 1485–1495
Hosoda K, Furuta T, Yokokawa A, Ishii K. Anal Bioanal Chem, 2010, 397: 1563–1572
Kgomotso T, Chiu F, Ng K. Mol Nutr Food Res, 2008, 52: 1457–1466
Robert C, Thomas L, Bondarenko I, O’Day S, Weber J, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller Jr WH, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD. N Engl J Med, 2011, 364: 2517–2526
Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, Natale RB, Cooper RM, Barlogie B, Trump DL. J Clin Oncol, 1993, 11: 1276–1285
Larsimont V, Meins J, Fieger-Bü schges H, Henning Blume H. J Chromatogr B-Biomed Sci Appl, 1998, 719: 222–226
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81373373, 21435002, 21621003).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Jie, M., Lin, H., He, Z. et al. An on-chip intestine-liver model for multiple drugs absorption and metabolism behavior simulation. Sci. China Chem. 61, 236–242 (2018). https://doi.org/10.1007/s11426-017-9167-0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-017-9167-0